Clinical Ink, developer of eSource technology for clinical trials with Philly-area office, raises $4.3 million
Tom Paine
Follow @phillytechnews
Subscribe in a readerSubscribe to Philadelphia Tech News by Email
Clinical Ink, a pioneer in the development of eSource technology for use in clinical trials with offices in Winston Salem and Philadelphia, has landed a $4.3M Series B Investment Round led by FCA Venture Partners.
Clinical Ink's platform mimics the look, feel and usability of a paper chart on a tablet device (including use of a stylus for input) and enables data entry during patient visits rather than afterwords. Clinical Ink says it has been recognized by the Society of Clinical Data Management, Microsoft, and Gartner Research as having "significant disruptive potential" to transform the current clinical trial business model.
FCA Venture Partners, the venture capital manager of Clayton Associates, was founded in 1996 by R. Clayton McWhorter, founder of HealthTrust, Inc. and former chairman of Hospital Corporation of America. Founded in 2007, Clinical Ink's Philadelphia office appears to be
located in Horsham.
No comments:
Post a Comment